Fig. 3: Standard muscle imaging by ultrasound and magnetic resonance imaging does not show discernable differences in biceps muscles of LOPD patients. | Nature Communications

Fig. 3: Standard muscle imaging by ultrasound and magnetic resonance imaging does not show discernable differences in biceps muscles of LOPD patients.

From: Non-invasive optoacoustic imaging of glycogen-storage and muscle degeneration in late-onset Pompe disease

Fig. 3

A Ultrasound images (top row) and In-Phase (middle row) and Fat-Phase (bottom-row) MRI of the biceps muscle. From left to right, HV, mildly, moderately and severely affected LOPD patients. Elliptic (blue) and polygonal (yellow) ROI used in RUCT images and circular ROI used in Fat-Phase MRI for quantification. B Mean GSL values of matched HV vs. LOPD patients using an elliptic ROI. C Mean GSL values of matched HV vs. LOPD patients using a polygonal ROI. Each independent muscle region was scanned twice. Results represent 80 datasets from n = 40 independent biceps muscle regions (n = 20 HV/n = 20 LOPD) in n = 20 biologically independent subjects (n = 10 HV and n = 10 patients with LOPD). Each filled dot represents one MSOT signal per mean biceps muscle region (4 datasets from n = 2 independent independent muscle regions from one biologically independent subject). HV are represented with green and LOPD patients with violet dots. D ROIs in MRI images were manually placed in transversal slices of the right biceps brachii muscle corresponding to the position of MSOT evaluation. Results represent 20 datasets from n = 20 independent biceps muscle regions (n = 10 HV/n = 10 LOPD) in n = 20 biologically independent subjects (n = 10 HV and n = 10 patients with LOPD). Each filled circle represents the fat fraction in percent per tissue signal per mean right biceps muscle (1 dataset from n = 1 independent muscle region from one biologically independent subject). HV are represented with green and LOPD patients with violet dots. To display differences in fat fractions, mean values from HV were subtracted from LOPD patients. One black dot represents one calculated ratio. Confidence intervals represent 95% CI ranging from −4.957 to 14.16, effect size (R2) 0.1164, mean of differences (LOPD – HV) 4.6, SD of differences 13.36, SEM of differences 4.225. Two-tailed dependent samples t-tests (matched for age and sex) were used for statistical analysis. If the assumption of normal distribution was violated, a Wilcoxon signed-rank was used. P ≤ 0.05 was considered statistically significant. HV healthy volunteer, LOPD late-onset Pompe disease patient, ROI region of interest, RUCT reflected ultrasound computed tomography, MRI magnetic resonance imaging.

Back to article page